Melanoma cancer vaccines and antitumor T cell responses, J. Cell Biochem, vol.102, pp.301-310, 2007. ,
Peptide-specific CD81T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1, Int. J. Cancer, vol.98, pp.376-388, 2002. ,
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides, Int. J. Cancer, vol.86, pp.538-547, 2000. ,
Infusion of Melan-A/Mart-1 melanoma patients, Cancer Immunol. Immunother, vol.56, pp.515-526, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482050
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, pp.850-854, 2002. ,
Phase I study of adoptive T-cell therapy using antigenspecific CD81T cells for the treatment of patients with metastatic melanoma, J. Clin. Oncol, vol.24, pp.5060-5069, 2006. ,
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients ,
, J. Immunol, vol.170, pp.2161-2169, 2003.
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J. Immunol, vol.175, pp.4797-4805, 2005. ,
Adoptive T cell therapy using antigen-specific CD81T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells, Proc. Natl. Acad. Sci, vol.99, pp.16168-16173, 2002. ,
, Clinical immunology, vol.40, pp.1786-1794, 2010.
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, J. Exp. Med, vol.205, pp.2673-2682, 2008. ,
Self-antigen-specific CD81T cell precursor frequency determines the quality of the antitumor immune response, J. Exp. Med, vol.206, pp.849-866, 2009. ,
A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response ,
, J. Immunol, vol.165, pp.6644-6652, 2000.
Melan-A/MART-1-specific CD8 T cells: from thymus to tumor, Trends Immunol, vol.23, pp.325-328, 2002. ,
Thymic selection generates a large T cell pool recognizing a self-peptide in humans, J. Exp. Med, vol.195, pp.485-494, 2002. ,
Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer, Int. J. Cancer, vol.77, pp.538-542, 1998. ,
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated selfantigen, J. Immunol, vol.170, pp.5103-5109, 2003. ,
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens, Eur. J. Immunol, vol.32, pp.3181-3190, 2002. ,
Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids, Immunity, vol.8, pp.403-411, 1998. ,
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen, Science, vol.279, pp.1166-1172, 1998. ,
Naïve CD4(1)T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude, Immunity, vol.27, pp.203-213, 2007. ,
CD81T-cell memory in tumor immunology and immunotherapy, Immunol. Rev, vol.211, pp.214-224, 2006. ,
Central memory self/tumorreactive CD81T cells confer superior antitumor immunity compared with effector memory T cells, Proc. Natl. Acad. Sci, vol.102, pp.9571-9576, 2005. ,
Functionally distinct CD8 1 memory T cell subsets in persistent EBV infection are differentiate d by migratory receptor expression, Eur. J. Immunol, vol.30, pp.1823-1829, 2000. ,
Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat. Med, vol.6, pp.707-710, 2000. ,
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol. Immunother, vol.57, pp.185-195, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00167752
High frequencies of naïve Melan-A/ MART-1-specific CD8(1) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals, J. Exp. Med, vol.190, pp.705-715, 1999. ,
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen, Proc ,
, Natl. Acad. Sci. USA, vol.101, pp.14631-14638, 2004.
Naturally occurring human lymphocyte antigen-A2 restricted CD81T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, Cancer Res, vol.60, pp.4499-4506, 2000. ,
Characterization of Melan-A reactive memory CD81T cells in a healthy donor, Int. Immunol, vol.20, pp.1087-1096, 2008. ,
The shaping of the T cell repertoire, Immunity, vol.14, pp.21-32, 2001. ,
The imprint of intrathymic self-peptides on the mature T cell receptor repertoire, Immunity, vol.7, pp.517-524, 1997. ,
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482162
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991. ,
The tight interallelic positional coincidence that distinguishes T-cell receptor Jalpha usage does not result from homologous chromosomal pairing during ValphaJalpha rearrangement, EMBO J, vol.20, pp.4717-4729, 2001. ,
Human T-cell receptor variable gene segment families, Abbreviations: pMHC: peptide-MHC complexes Á TAA: Tumorassociated antigen Á TIL: tumor infiltrating lymphocytes Full correspondence: Dr. Nathalie Labarriere, CRCNA, Institut de Recherche Therapeutique, vol.42, p.44007, 1995. ,